MKSAP 17 Audio Companion - Neurology

• MKSAP_17_Audio_Companion_Neurology.pdf
• 1-01 Introduction to Neurology Section.m4a
• 1-02 Approach to the Patient with Headache.m4a
• 1-03 Secondary Headache Syndromes.m4a
• 1-04 Initial Workup of a Headache.m4a
• 1-05 Question Break 1 A 66-year-old Man is Seen for Increasingly Difficult-To-Manage Behaviors.m4a
• 1-06 Thunderclap Headache.m4a
• 1-07 Other Causes of Thunderclap Headache.m4a
• 1-08 Other Vascular Headaches.m4a
• 1-09 Treating RCVS.m4a
• 1-10 Question Break 2 A 56-year-old Man is Evaluated for Gradually Worsening Behavioral Problems.m4a
• 1-11 Idiopathic Intracranial Hypertension.m4a
• 1-12 Headaches from Intracranial Hypotension.m4a
• 1-13 Management.m4a
• 1-14 Trigeminal Neuralgia.m4a
• 1-15 Medication-Induced Headache.m4a
• 1-16 Session 1 Key Points.m4a
• 1-17 Close to Session 1.m4a
• 2-01 Introduction to Session 2.m4a
• 2-02 Clinical Features and Diagnosis of Migraine.m4a
• 2-03 Stroke Risk.m4a
• 2-04 Acute Migraine Management.m4a
• 2-05 Question Break 3 A 24-year-old Man is Seen for Management of Seizures.m4a
• 2-06 Refractory Migraine.m4a
• 2-07 Migraine Prevention.m4a
• 2-08 Migraine Preventive Therapies.m4a
• 2-09 Tension-Type Headache.m4a
• 2-10 Question Break 4 A 55-year-old Man is Seen in the ED for Convulsive Status Epilepticus.m4a
• 2-11 Cluster Headache.m4a
• 2-12 Other Primary Headache Syndromes.m4a
• 2-13 Traumatic Brain Injury.m4a
• 2-14 Head Injury in Athletes.m4a
• 2-15 Head Injury in Military Personnel and Older Patients.m4a
• 2-16 Postconcussion Syndrome.m4a
• 2-17 Session 2 Key Points.m4a
• 2-18 Close to Session 2.m4a
• 3-01 Introduction to Session 3.m4a
• 3-02 Epidural and Subdural Hematoma.m4a
• 3-03 Clinical Presentation of Seizures.m4a
• 3-04 Partial Seizures.m4a
• 3-05 Generalized Seizures.m4a
• 3-06 Focal Epilepsy.m4a
• 3-07 Idiopathic Generalized Epilepsy.m4a
• 3-08 Question Break 5 A 29-year-old Woman is Seen for a Follow-Up Exam of her Multiple Sclerosis.m4a
• 3-09 Initial Approach to the Patient with a First Seizure.m4a
• 3-10 Provoked Seizures.m4a
• 3-11 Nonepileptic Seizures.m4a
• 3-12 Imaging Studies.m4a
• 3-13 Question Break 6 A 35-year-old Man is Seen for Midback Pain and Bilateral Leg Numbness.m4a
• 3-14 Epilepsy Monitoring Units.m4a
• 3-15 Continuous EEG Monitoring.m4a
• 3-16 Antiepileptic Drug Therapy.m4a
• 3-17 Selection of Antiepileptic Drugs.m4a
• 3-18 Monitoring and Discontinuing Medications.m4a
• 3-19 Counseling and Lifestyle Adjustments.m4a
• 3-20 Comorbidities and Complications of Epilepsy.m4a
• 3-21 Session 3 Key Points.m4a
• 3-22 Close to Session 3.m4a
• 4-01 Introduction to Session 4.m4a
• 4-02 Seizures and Epilepsy in Older Patients.m4a
• 4-03 Patients with Organ Failure and Returning Combat Veterans.m4a
• 4-04 Women and Epilepsy.m4a
• 4-05 Contraception.m4a
• 4-06 Convulsive Status Epilepticus.m4a
• 4-07 Nonconvulsive Status Epilepticus.m4a
• 4-08 Definition of Stroke.m4a
• 4-09 Diagnosis of Stroke.m4a
• 4-10 Question Break 7 A 48-year-old Man is Evaluated for Right Upper Extremity Weakness.m4a
• 4-11 Transient Ischemic Attack.m4a
• 4-12 Cardioembolic Stroke.m4a
• 4-13 Large Artery Atherosclerosis.m4a
• 4-14 Small Subcortical Infarcts or Lacunes.m4a
• 4-15 Cryptogenic and Rare Causes of Stroke.m4a
• 4-16 Question Break 8 A 29-year-old Woman is Seen for Progressive Weakness, Sensory Symptoms, and Imbalance.m4a
• 4-17 Subarachnoid Hemorrhage.m4a
• 4-18 Intracerebral Hemorrhage.m4a
• 4-19 Acute Stroke Therapy.m4a
• 4-20 Antiplatelet, Anticoagulant, and Other Agents for Acute Ischemic Stroke.m4a
• 4-21 Antithrombotic Therapy after Ischemic Stroke.m4a
• 4-22 Intracerebral Hemorrhage Treatment.m4a
• 4-23 Subarachnoid Hemorrhage Treatment.m4a
• 4-24 Session 4 Key Points.m4a
• 4-25 Close to Session 4.m4a
• 5-01 Introduction to Session 5.m4a
• 5-02 Primary Stroke Prevention.m4a
• 5-03 Lifestyle and Medical Management for Secondary Stroke Prevention.m4a
• 5-04 Surgery for Secondary Ischemic Stroke Prevention.m4a
• 5-05 Neurologic Complications.m4a
• 5-06 Medical Complications and Stroke Units.m4a
• 5-07 Long-Term Prognosis and Recovery.m4a
• 5-08 Question Break 9 An 18-year-old Man is Seen for Recurrent Headaches After a Fall.m4a
• 5-09 Definitions, Description, and Evaluation of Cognitive Impairment.m4a
• 5-10 Mild Cognitive Impairment.m4a
• 5-11 Dementia.m4a
• 5-12 Evaluation of the Patient with Suspected Cognitive Impairment.m4a
• 5-13 Screening Tests.m4a
• 5-14 Other Testing.m4a
• 5-15 Question Break 10 A 44-year-old Man is Seen for a Severe Global Headache and Blurred Vision.m4a
• 5-16 Alzheimer Disease.m4a
• 5-17 Neurochemistry, Pathology, and Biomarkers.m4a
• 5-18 Lewy Body Disease.m4a
• 5-19 Frontotemporal Dementia.m4a
• 5-20 Idiopathic Normal Pressure Hydrocephalus.m4a
• 5-21 Vascular Neurocognitive Disorder.m4a
• 5-22 Dementia Associated with Traumatic Brain Injury.m4a
• 5-23 Session 5 Key Points.m4a
• 5-24 Close to Session 5.m4a
• 6-01 Introduction to Session 6.m4a
• 6-02 Mixed Dementias.m4a
• 6-03 Pharmacologic Therapies for Cognitive Symptoms.m4a
• 6-04 Neuropsychiatric Symptoms in Cognitive Impairment.m4a
• 6-05 Treatment of Neuropsychiatric Symptoms.m4a
• 6-06 Delirium.m4a
• 6-07 Question Break 11 A 57-year-old Man is Seen for Follow-Up After a Carotid Ultrasound.m4a
• 6-08 Overview of Movement Disorders.m4a
• 6-09 Hypokinetic Movement Disorders.m4a
• 6-10 Clinical Features of Parkinson Disease.m4a
• 6-11 Diagnosis of Parkinson Disease.m4a
• 6-12 Treatment of Parkinson Disease.m4a
• 6-13 Risk of Adverse Effects.m4a
• 6-14 Medication Options.m4a
• 6-15 Question Break 12 A 45-year-old Man is Seen for Significant Fatigue After a Lacunar Stroke.m4a
• 6-16 Parkinson Plus Syndromes.m4a
• 6-17 Drug-Induced Parkinsonism.m4a
• 6-18 Hyperkinetic Movement Disorders.m4a
• 6-19 Dystonia.m4a
• 6-20 Choreiform Disorders and Huntington Disease.m4a
• 6-21 Tic Disorders and Tourette Syndrome.m4a
• 6-22 Restless Legs Syndrome and Sleep-Related Movement Disorders.m4a
• 6-23 Tardive Dyskinesia.m4a
• 6-24 Neuroleptic Malignant Syndrome.m4a
• 6-25 Session 6 Key Points.m4a
• 6-26 Close to Session 6.m4a
• 7-01 Introduction to Session 7.m4a
• 7-02 Spectrum, Pathophysiology, and Epidemiology of Multiple Sclerosis.m4a
• 7-03 Presenting Signs and Symptoms.m4a
• 7-04 Diagnostic Criteria and Testing.m4a
• 7-05 Differential Diagnosis of Multiple Sclerosis.m4a
• 7-06 Clinical Course of Multiple Sclerosis.m4a
• 7-07 Treatment of Multiple Sclerosis.m4a
• 7-08 Treatment of Acute Exacerbations.m4a
• 7-09 Disease-Modifying Therapies.m4a
• 7-10 Choosing an Appropriate Therapy.m4a
• 7-11 Symptomatic Management.m4a
• 7-12 Spacticity, Fatigue and Cognitive Dysfunction.m4a
• 7-13 Session 7 Key Points.m4a
• 7-14 Close to Session 7.m4a
• 8-01 Introduction to Session 8.m4a
• 8-02 Disorders of the Spinal Cord.m4a
• 8-03 Clinical Presentation of Compressive Myelopathies.m4a
• 8-04 Diagnosis and Treatment.m4a
• 8-05 Idiopathic Transverse Myelitis.m4a
• 8-06 Subacute Combined Degeneration.m4a
• 8-07 Vascular Disorders and Genetic Testing.m4a
• 8-08 Overview of Peripheral Neuropathies.m4a
• 8-09 Classification, Findings, and Diagnosis.m4a
• 8-10 Additional Laboratory Testing in Peripheral Neuropathy.m4a
• 8-11 Mononeuropathies.m4a
• 8-12 Carpal Tunnel Syndrome.m4a
• 8-13 Bell Palsy and Brachial and Lumbosacral Plexopathies.m4a
• 8-14 Polyneuropathies.m4a
• 8-15 Hereditary Neuropathies.m4a
• 8-16 Guillain-Barre Syndrome.m4a
• 8-17 Session 8 Key Points.m4a
• 8-18 Close to Session 8.m4a
• 9-01 Introduction to Session 9.m4a
• 9-02 Chronic Inflammatory Demyelinating Polyradiculoneuropathy.m4a
• 9-03 Critical Illness Neuropathy.m4a
• 9-04 Systemic Neuropathy.m4a
• 9-05 Paraproteinemic Neuropathy, Amyloid Neuropathy and MGUS.m4a
• 9-06 Amyotrophic Lateral Sclerosis.m4a
• 9-07 Myasthenia Gravis.m4a
• 9-08 Lambert-Eaton Myasthenic Syndrome.m4a
• 9-09 Overview of Myopathies.m4a
• 9-10 Inflammatory Myopathy and Endocrine-Related Myopathy.m4a
• 9-11 Glucocorticoid-Induced Myopathy.m4a
• 9-12 Toxic Myopathy and Inherited Myopathies.m4a
• 9-13 Intracranial Tumors.m4a
• 9-14 Clinical and Radiographic Features of Intracranial Tumors.m4a
• 9-15 Other Tests.m4a
• 9-16 Metastatic Brain Tumors.m4a
• 9-17 Primary Central Nervous System Gliomas and Lymphoma.m4a
• 9-18 Meningiomas and Management of Metastatic Brain Tumors.m4a
• 9-19 Management of Primary Central Nervous System Gliomas and Lymphoma.m4a
• 9-20 Management of Meningiomas.m4a
• 9-21 Medical Management of Complications of Primary Central Nervous System Tumors.m4a
• 9-22 Paraneoplastic Neurologic Syndromes.m4a
• 9-23 Testing.m4a
• 9-24 Session 9 Key Points.m4a
• 9-25 Close to Neurology Section.m4a